about
The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central AsiaTuberculosis recurrence and mortality after successful treatment: impact of drug resistanceMultidrug-resistant tuberculosis treatment outcomes in Karakalpakstan, Uzbekistan: treatment complexity and XDR-TB among treatment failuresGenomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprintsRisk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysisPublic health advocacy for the Berlin Declaration on tuberculosis in the former Soviet Union: The view of Médecins Sans FrontièresHigh genetic diversity among Mycobacterium tuberculosis complex strains from Sierra Leone.Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimatesMycobacterium tuberculosis Beijing lineage favors the spread of multidrug-resistant tuberculosis in the Republic of Georgia.Global and Regional Burden of Isoniazid-Resistant TuberculosisIsoniazid-resistant tuberculosis in children: a systematic reviewPrevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study.High prevalence of multidrug-resistant tuberculosis in Georgia.Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients.High frequency of resistance to the drugs isoniazid and rifampicin among tuberculosis cases in the city of Cabo de Santo Agostinho, an urban area in Northeastern Brazil.Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs.Mycobacterium tuberculosis drug resistance, Abkhazia.Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: a docking and molecular dynamics study.Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
P2860
Q24814887-791AA802-BDA1-4A95-B3A1-685127A54EABQ28469052-D163F0EA-1F9B-4C36-BEFC-9801AE578319Q28469334-9A90C37F-28C1-4117-9DEC-9F9D3B340530Q28476294-A4F0A845-FD04-4167-AD24-7FAF5D50D67BQ28534902-E2A9F3F5-13A0-4A01-8A29-7361550A6383Q28535194-B0A12C70-68BC-474F-9A7F-3C3172F257D0Q33346635-BC19C685-C012-4085-B3E2-F9E67B0F29C6Q33889335-5F817A32-589F-4DAE-A228-3F64773A91B8Q34190370-F1BE8713-EEF6-4F4D-82E1-E34DD44BF282Q35795714-F7997FF6-89C2-416D-B871-4F7C2CE77634Q37004599-78B0B301-CC48-40BD-8592-C22B0DABC482Q37102892-6670E1AA-AAE8-47AD-92C6-A5D2C23C1F93Q37102931-9FE3C87F-FB33-4F27-8BA1-C03284C3B8BCQ37743569-BC8A091B-92FE-4A0B-AD3F-528AEF7A10F9Q39840755-EE459585-9AE0-49CC-ABE9-9B824C6C1AB0Q42183123-E0606F5A-675C-41E1-B7A3-84776CD611F9Q42590779-AEA32395-F20E-4339-B3FD-8FB0A6AC147FQ43169526-E1D7B429-CACE-4257-B931-DFB9845EAC30Q44309966-93B21626-F155-41D6-8CBE-5C974BDE9E5C
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multidrug-resistant tuberculosis in central Asia
@ast
Multidrug-resistant tuberculosis in central Asia
@en
type
label
Multidrug-resistant tuberculosis in central Asia
@ast
Multidrug-resistant tuberculosis in central Asia
@en
prefLabel
Multidrug-resistant tuberculosis in central Asia
@ast
Multidrug-resistant tuberculosis in central Asia
@en
P2093
P2860
P921
P356
P1476
Multidrug-resistant tuberculosis in central Asia
@en
P2093
Darebay Doshetov
Dennis Falzon
Helen Suzanne Cox
Juan Daniel Orozco
Mohammed Aziz
Sabine Ruesch-Gerdes
Yared Kebede
P2860
P304
P356
10.3201/EID1005.030718
P577
2004-05-01T00:00:00Z